Published on GHDx (https://ghdx.healthdata.org)

Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial

General Info

Geography 
Nepal (NPL)
Coverage type 
Country
Time period covered 
January, 2017 - December, 2021
Data type
Scientific literature
Keywords 
Typhoid and paratyphoid fevers, Typhoid and paratyphoid vaccines

Citation

Authors 
Shakya M, Voysey M, Theiss-Nyland K, Colin-Jones R, Pant D, Adhikari A, Tonks S, Mujadidi YF, O'Reilly P, Mazur O, Kelly S, Liu X, Maharjan A, Dahal A, Haque N, Pradhan A, Shrestha S, Joshi M, Smith N, Hill J, Clarke J, Stockdale L, Jones E, Lubinda T, Bajracharya B, Dongol S, Karkey A, Baker S, Dougan G, Pitzer VE, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ, TyVAC Nepal Team
Journal 
Lancet Glob Health
Pages 
e1561-e1568
Publication year 
2021
Suggested citation 
Shakya M, Voysey M, Theiss-Nyland K, Colin-Jones R, Pant D, Adhikari A, Tonks S, Mujadidi YF, O'Reilly P, Mazur O, Kelly S, Liu X, Maharjan A, Dahal A, Haque N, Pradhan A, Shrestha S, Joshi M, Smith N, Hill J, Clarke J, Stockdale L, Jones E, Lubinda T, Bajracharya B, Dongol S, Karkey A, Baker S, Dougan G, Pitzer VE, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ, TyVAC Nepal Team. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial. Lancet Glob Health. 2021; 9(11): e1561-e1568.
Source URL:https://ghdx.healthdata.org/record/efficacy-typhoid-conjugate-vaccine-nepal-final-results-phase-3-randomised-controlled-trial#comment-0